- Home
- JEQ vs XTNT Comparison
JEQ vs XTNT Comparison
Compare JEQ & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- XTNT
- Stock Information
- Founded
- JEQ 1990
- XTNT N/A
- Country
- JEQ United States
- XTNT United States
- Employees
- JEQ N/A
- XTNT N/A
- Industry
- JEQ Air Freight/Delivery Services
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JEQ Consumer Discretionary
- XTNT Health Care
- Exchange
- JEQ Nasdaq
- XTNT Nasdaq
- Market Cap
- JEQ 79.2M
- XTNT 69.3M
- IPO Year
- JEQ N/A
- XTNT N/A
- Fundamental
- Price
- JEQ $5.66
- XTNT $0.52
- Analyst Decision
- JEQ
- XTNT Strong Buy
- Analyst Count
- JEQ 0
- XTNT 1
- Target Price
- JEQ N/A
- XTNT $3.00
- AVG Volume (30 Days)
- JEQ 32.0K
- XTNT 83.6K
- Earning Date
- JEQ 01-01-0001
- XTNT 11-12-2024
- Dividend Yield
- JEQ 7.05%
- XTNT N/A
- EPS Growth
- JEQ N/A
- XTNT N/A
- EPS
- JEQ N/A
- XTNT N/A
- Revenue
- JEQ N/A
- XTNT $113,862,000.00
- Revenue This Year
- JEQ N/A
- XTNT $31.27
- Revenue Next Year
- JEQ N/A
- XTNT $13.07
- P/E Ratio
- JEQ N/A
- XTNT N/A
- Revenue Growth
- JEQ N/A
- XTNT 45.11
- 52 Week Low
- JEQ $4.99
- XTNT $0.33
- 52 Week High
- JEQ $6.39
- XTNT $1.30
- Technical
- Relative Strength Index (RSI)
- JEQ 42.69
- XTNT 63.76
- Support Level
- JEQ $5.61
- XTNT $0.49
- Resistance Level
- JEQ $5.73
- XTNT $0.55
- Average True Range (ATR)
- JEQ 0.06
- XTNT 0.07
- MACD
- JEQ -0.01
- XTNT 0.01
- Stochastic Oscillator
- JEQ 25.93
- XTNT 63.16
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.